The Federal Trade Commission today accused Invibio Inc., a Conshohocken-based, British-owned company that supplies medical-device makers with high-tech materials for spinal implants and other medical devices, of illegally keeping prices high “by using long-term exclusive contracts to maintain its monopoly.”
Invibio agreed to settle the FTC’s charges, FTC says in this statement. Andrew Hanson, a spokesman for Invibio’s owner, Victrex PLC, told me the company can’t comment today on the settlement. More about FTC accusations here, settlement order here, FTC analysis here.
